Emerfetamab

AMG 673 · Amgen

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Emerfetamab, covering 2023-09-01 to 2023-09-01. Get the full timeline:

Most recent: Clinical Trial Update: Study of Emerfetamab (AMG 673) in Adults With Relapsed/Refractory Acute Myeloid Leukemia (AML) [EARLY_Phase 1]